07:00 , Sep 12, 2016 |  BC Week In Review  |  Financial News

GeneNews completes private placement of units

GeneNews Ltd. (TSX:GEN), Markham, Ontario   Business: Diagnostic   Date completed: 2016-09-02   Type: Private placement of units   Raised: C$1.6 million ($1.2 million)   Units: 9.8 million   Price: C$0.16 (unit)   Shares after...
07:00 , Jun 13, 2016 |  BC Week In Review  |  Financial News

GeneNews financial update

GeneNews Ltd. (TSX:GEN), Markham, Ontario   Business: Diagnostic   Date announced: 2016-06-09   Note: GeneNews secured a C$5 million ($3.9 million) capital commitment from GEM Global Yield Fund. GeneNews may draw down the funds over...
07:00 , Apr 11, 2016 |  BC Week In Review  |  Financial News

GeneNews completes private placement

GeneNews Ltd. (TSX:GEN), Markham, Ontario   Business: Diagnostic   Date completed: 2016-04-07   Type: Private placement   Raised: C$560,000 ($428,232)   Shares: 5.6 million   Price: C$0.10   Shares after offering: 61.6 million   Investor:...
07:00 , Mar 21, 2016 |  BC Week In Review  |  Financial News

GeneNews proposes private placement

GeneNews Ltd. (TSX:GEN), Markham, Ontario   Business: Diagnostic   Date announced: 2016-03-14   Type: Private placement   To be raised: Up to C$5 million ($3.8 million)   Shares: 50 million   Price: C$0.10   Shares...
08:00 , Jan 4, 2016 |  BioCentury  |  Finance

Big band swing

Many investors treated biotech's dismal 3Q15 as a buying opportunity, and the effects were apparent in 4Q15. All of the market cap bands showed positive gains save for the microcaps. Big biotechs led the charge...
08:00 , Nov 24, 2014 |  BC Week In Review  |  Company News

sphingotec, GeneNews deal

GeneNews received rights to sphingotec’s breast cancer risk assessment assays, sphingotest pro-NT and sphingotest pro-ENK. GeneNews plans to add by early 2015 the sphingotest pro-NT to the advanced cancer assays offered by its JV, Innovative...
07:00 , Jul 14, 2014 |  BC Week In Review  |  Financial News

GeneNews Ltd completes private placement

GeneNews Ltd . (TSX:GEN), Richmond Hill, Ontario   Business: Cancer, Cardiovascular, Neurology   Date completed: 2014-07-08   Type: Private placement   Raised: C$7.2 million ($6.8 million)   Shares: 7 million   Price: C$1.03   Shares...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Danaher, Innovative Diagnostic Laboratory LLP sales and marketing update

Innovative Diagnostic launched the multivariate Prostate Health Index (phi) in the U.S. Innovative Diagnostic is a JV between GeneNews Ltd. (TSX:GEN, Richmond Hill, Ontario), Health Diagnostic Laboratory Inc. (Richmond, Va.) and an undisclosed sales company....
08:00 , Jan 27, 2014 |  BC Week In Review  |  Company News

Innovative Diagnostic Laboratory LLP sales and marketing update

Innovative Diagnostic launched the ColonSentry blood test in the U.S. to assess a patient's risk for colorectal cancer. The company launched the blood-based test for seven mRNA biomarkers of colorectal cancer on a limited basis...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

GeneNews financial update

GeneNews converted C$4.8 million ($4.5 million) in outstanding debt plus accrued interest into about 10.2 million shares at C$0.47 per share. GeneNews said the conversion represents 87% of all principal outstanding. The company paid C$250,000...